BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ao L, Li L, Sun H, Chen H, Li Y, Huang H, Wang X, Guo Z, Zhou R. Transcriptomic analysis on the effects of melatonin in gastrointestinal carcinomas. BMC Gastroenterol 2020;20:233. [PMID: 32689938 DOI: 10.1186/s12876-020-01383-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Fernández-Palanca P, Méndez-Blanco C, Fondevila F, Tuñón MJ, Reiter RJ, Mauriz JL, González-Gallego J. Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review. Antioxidants (Basel) 2021;10:103. [PMID: 33445767 DOI: 10.3390/antiox10010103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
2 Zou Y, Sun H, Guo Y, Shi Y, Jiang Z, Huang J, Li L, Jiang F, Lin Z, Wu J, Zhou R, Liu Y, Ao L. Integrative Pan-Cancer Analysis Reveals Decreased Melatonergic Gene Expression in Carcinogenesis and RORA as a Prognostic Marker for Hepatocellular Carcinoma. Front Oncol 2021;11:643983. [PMID: 33842355 DOI: 10.3389/fonc.2021.643983] [Reference Citation Analysis]
3 Reiter RJ, Sharma R, Rodriguez C, Martin V, Rosales-Corral S, Zuccari DAPC, Chuffa LGA. Part-time cancers and role of melatonin in determining their metabolic phenotype. Life Sci 2021;278:119597. [PMID: 33974932 DOI: 10.1016/j.lfs.2021.119597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]